Alkermes plc. — Director's Dealing 2021

Jun 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2021-06-07

Reporting Person: Hopkinson Craig C. (EVP R&D, Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-07	Ordinary Shares	M	1250	—	Acquired	1250	Direct
2021-06-07	Ordinary Shares	F	368	$23.50	Disposed	882	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-07	Restricted Stock Unit Award	$0	M	1250	Disposed		Ordinary Shares (1250)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: This award is fully vested in accordance with its terms.